Literature DB >> 389806

In vitro investigations with fosfomycin on Mueller-Hinton agar with and without glucose-6-phosphate.

H Grimm.   

Abstract

Determination of the minimal inhibitory concentration of fosfomycin in the agar dilution test on Mueller-Hinton agar showed that the addition of glucose-6-phosphate to the nutrient medium potentiates the action of fosfomycin against Escherichia coli, Klebsiella, Enterobacter, Citrobacter and Staphylococcus aureus, sometimes by as much as 256-fold. Such a potentiation of action was not detectable with Serratia marcescens, the individual Proteus species, Pseudomonas aeruginosa or enterococci. Fosfomycin is very effective against most medically important bacterial species on Mueller-Hinton agar containing 25 micrograms/ml glucose-6-phosphate. Over 90% of the cultures of E. coli, Citrobacter, Enterobacter, S. marcescens,Proteus mirabilis, Proteus vulgaris, Proteus rettgeri, P. aeruginosa, S. aureus and enterococci examined were inhibited by less than or equal to 64 micrograms/ml fosfomycin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 389806     DOI: 10.1007/bf01648937

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  17 in total

1.  [In vitro investigations of rifampicin. Correlation between minimal inhibitory concentration and minimal inhibitory zone].

Authors:  H Grimm
Journal:  Arzneimittelforschung       Date:  1978

2.  The evolution of the sensitivity to fosfomycin over the past two years.

Authors:  M Gobernado; M Santos; N Diosdado; F Pérez
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

3.  Evolution of sensitivity to fosfomycin in bacteria isolated in 1973, 1974 and 1975 in the Servicio de Microbiologia y Epidemiologia of the 'Clinica Puerta de Hierro', Madrid.

Authors:  D Dámaso; M Moreno-López; J Martínez-Beltrán
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

4.  Evolution of sensitivity to fosfomycin at Jimenez Diaz Foundation.

Authors:  J M Alés
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

5.  Evolution of bacterial sensitivity to fosfomycin in the Cindad Sanitaria 'Francisco Franco' in Barcelona.

Authors:  E Crespo; J A Roca de Viñals
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

6.  Susceptibility to fosfomycin of hospital strains isolated in Nantes (France). Frequency of mutation to resistance.

Authors:  A L Courtieu; H Drugeon; S Billaudel
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

7.  Fosfomycin and plasmidic resistance.

Authors:  F Baquero; M López-Brea; A Valls; T Cañedo
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

8.  [Investigations on the antibacterial activity of fosfomycin on DST-agar (author's transl)].

Authors:  A Hirschl; M Rotter; H Maruna
Journal:  Zentralbl Bakteriol Orig A       Date:  1978-12

9.  Fosfomycin: Laboratory studies.

Authors:  H B Woodruff; J M Mata; S Hernández; S Mochales; A Rodríguez; E O Stapley; H Wallick; A K Miller; D Hendlin
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

10.  Fosfomycin, antimicrobial activity in vitro and in vivo.

Authors:  S Goto
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

View more
  7 in total

1.  Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance.

Authors:  F Docobo-Pérez; G L Drusano; A Johnson; J Goodwin; S Whalley; V Ramos-Martín; M Ballestero-Tellez; J M Rodriguez-Martinez; M C Conejo; M van Guilder; J Rodríguez-Baño; A Pascual; W W Hope
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

2.  Glucose-6-phosphate Reduces Fosfomycin Activity Against Stenotrophomonas maltophilia.

Authors:  Teresa Gil-Gil; José Luis Martínez
Journal:  Front Microbiol       Date:  2022-05-10       Impact factor: 6.064

3.  [Fosfomycin concentrations in serum and bile (author's transl)].

Authors:  O Müller; U Rückert; W Walter; R Haag; W Sauer
Journal:  Infection       Date:  1982-01       Impact factor: 3.553

4.  In vitro interactions between different beta-lactam antibiotics and fosfomycin against bloodstream isolates of enterococci.

Authors:  M Pestel; E Martin; C Aucouturier; J F Lemeland; F Caron
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

5.  Coordinated regulation of transcription by CcpA and the Staphylococcus aureus two-component system HptRS.

Authors:  Joseph M Reed; Sean Olson; Danielle F Brees; Caitlin E Griffin; Ryan A Grove; Paul J Davis; Stephen D Kachman; Jiri Adamec; Greg A Somerville
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

Review 6.  Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance.

Authors:  Alfredo Castañeda-García; Jesús Blázquez; Alexandro Rodríguez-Rojas
Journal:  Antibiotics (Basel)       Date:  2013-04-16

7.  In Vitro Activity of Newer and Conventional Antimicrobial Agents, Including Fosfomycin and Colistin, against Selected Gram-Negative Bacilli in Kuwait.

Authors:  Wadha Alfouzan; Rita Dhar; David P Nicolau
Journal:  Pathogens       Date:  2018-09-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.